| Literature DB >> 35061508 |
Nancy Zaborowski1, Amy Scheu2, Nicole Glowacki3, Mark Lindell4, Kimberly Battle-Miller2.
Abstract
Background: Palliative care improves health outcomes and satisfaction and supports decision-making for patients and families during challenging times in their lives. Earlier referral for consults has demonstrated increased costs savings.Hypothesis: Education proposing physicians order a palliative care consult within 3 days of patient hospital admission will decrease patient length of stay (LOS) and overall costs as well as expedite the transition to next level of care.Design/Method: A descriptive retrospective cohort study was completed using de-identified data originally captured for a system-wide initiative at a large acute care hospital in Illinois. Hospitalists were selected as the pilot group and received education encouraging physicians to order palliative care consults within 3 days of patient admission. Non-hospitalists (control group) did not receive the education. All results were compared to a 3-month baseline period.Entities:
Keywords: cost savings; decrease length of stay; early consult; end of life; palliative care; referral timing
Mesh:
Year: 2022 PMID: 35061508 PMCID: PMC9527348 DOI: 10.1177/10499091211067811
Source DB: PubMed Journal: Am J Hosp Palliat Care ISSN: 1049-9091 Impact factor: 2.090
Average Length of Stay (LOS) among Patients with a Palliative Consult.
| Baseline N = 367 | Pilot N = 138 | Control N = 206 | ||
|---|---|---|---|---|
| LOS admission to palliative Consult | 4.8 + 6.5 | 3.7 + 4.2 | 5 + 8.1 | .08 |
| LOS palliative consult to Discharge | 6.6 + 7.6 | 6.0 + 9.4 | 6.7 + 11.2 | .57 |
| Total LOS | 11.5 + 11.2 | 9.4 + 7.8 | 11.2 + 10.4 | .08 |
Figure 1.Average patient cost prior to and during the pilot program. Direct cost analysis includes the full cost of care for a patient, including staffing, building and associated equipment costs along with patient testing, supplies, staffing, etc.
Type of Diagnosis.
| Pilot N = 138 | Control N = 206 | ||
|---|---|---|---|
| Sepsis unspecified organism | 30 (22%) | 34 (17%) | .16 |
| Not documented (A41.9) | 25 (18%) | 38 (18%) | |
| Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease or unspecified chronic kidney disease (I13.0) | 11 (8%) | 7 (3%) | |
| Other (<3% of any 1 diagnosis) | 72 (52%) | 127 (62%) |
Length of Stay by Diagnosis.
| LOS Pre-Consult | LOS-Post Consult | Total LOS | ||||
|---|---|---|---|---|---|---|
| PilotN = 138 | ControlN = 206 | PilotN = 138 | ControlN = 206 | PilotN = 138 | ControlN = 206 | |
| Sepsis unspecified organism (A41.90029 | 2.7 | 5.6 | 4.5 | 4.9 | 7.2 | 10.5 |
| Not documented | 5.5 | 5.7 | 9.5 | 10.7 | 15.1 | 16.7 |
| Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease or unspecified chronic kidney disease (I13.0) | 3.3 | 3.9 | 6.1 | 9.1 | 9.4 | 13 |